Summary of findings for multi‐dose nasal decongestant vs placebo
Secondary outcome: all adverse events · adult patients with the common cold
Summary of findings for multi‐dose nasal decongestant showed no clear difference in secondary outcome: all adverse events compared with placebo (low certainty).
1 finding from 1 review
- OR 0.98 [0.68, 1.4]7 studies · 1195 participantsLow